行业盛典 再启新程|第七届中国医药创新与投资大会初版日程发布

Ryushi Shinagawa

Partner, Susquehanna International Group

Ryushi Shinagawa has over 10 years of investment experience in healthcare sector, leading/participating in the investment and post-investment management of Finch Therapeutics (FNCH), XtalPi, Synaptic Medical, Leader Medical, Cloud of Wisdom, Stonewise, and Netrain etc. Before joining SIG, he worked in Fosun Group and HNA Group, participated in their respective healthcare investments. Ryushi Shinagawa received MBA from Guanghua School of Management Peking University. He also holds Bachelor of Philosophy and Bachelor of Economics from Brandeis University.